npj Digital Medicine · 2020 · 1.1K citations · 15 references
ComputingComputer ScienceArtificial IntelligenceMachine LearningRegulatory ScienceArtificial Intelligence PolicyDevice RegulationDrug ApprovalMarket Authorization ProceduresMachine Learning For HealthcareMedical Device AuthorizationPremarket Approval
The AI/ML era promises broad diagnostic and therapeutic advances, yet regulatory hurdles remain a major barrier to clinical adoption. This study aims to catalog FDA‑approved AI/ML medical devices and highlight the need for clear regulatory labeling. By cross‑checking FDA approvals, the authors identified 64 AI/ML devices and created an open‑access, continuously updated database. Only 45 % of the devices explicitly reference AI/ML in FDA announcements, with 86 % cleared via 510(k), and the majority serve radiology, cardiology, and internal medicine.
At the beginning of the artificial intelligence (AI)/machine learning (ML) era, the expectations are high, and experts foresee that AI/ML shows potential for diagnosing, managing and treating a wide variety of medical conditions. However, the obstacles for implementation of AI/ML in daily clinical practice are numerous, especially regarding the regulation of these technologies. Therefore, we provide an insight into the currently available AI/ML-based medical devices and algorithms that have been approved by the US Food & Drugs Administration (FDA). We aimed to raise awareness of the importance of regulatory bodies, clearly stating whether a medical device is AI/ML based or not. Cross-checking and validating all approvals, we identified 64 AI/ML based, FDA approved medical devices and algorithms. Out of those, only 29 (45%) mentioned any AI/ML-related expressions in the official FDA announcement. The majority (85.9%) was approved by the FDA with a 510(k) clearance, while 8 (12.5%) received de novo pathway clearance and one (1.6%) premarket approval (PMA) clearance. Most of these technologies, notably 30 (46.9%), 16 (25.0%), and 10 (15.6%) were developed for the fields of Radiology, Cardiology and Internal Medicine/General Practice respectively. We have launched the first comprehensive and open access database of strictly AI/ML-based medical technologies that have been approved by the FDA. The database will be constantly updated.
15
Deep Learning—A Technology With the Potential to Transform Health Care
Geoffrey E. Hinton · JAMA · 2018 · 678 citations
Artificial Intelligence in Health Care
Michael E. Matheny, Danielle Whicher, Sonoo Thadaney Israni · JAMA · 2019 · 636 citations